We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Harlan Contract Research Services Cytotest Cell Research Selected for Membership in EU-NETVAL
News

Harlan Contract Research Services Cytotest Cell Research Selected for Membership in EU-NETVAL

Harlan Contract Research Services Cytotest Cell Research Selected for Membership in EU-NETVAL
News

Harlan Contract Research Services Cytotest Cell Research Selected for Membership in EU-NETVAL

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Harlan Contract Research Services Cytotest Cell Research Selected for Membership in EU-NETVAL"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

EU-NETVAL provides support for the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) to develop methods to reduce, refine or replace animals used for scientific purposes.

“Being in the initial group of laboratories acknowledges the expertise of our scientists as well as our continuous work in and support for alternative in vitro methodologies, including our participation in EU validation projects in the past,” said Dr. Albrecht Poth, deputy managing director and scientific advisor for Harlan CRS Cytotest Cell Research. “We are honored to have Harlan CRS play a role in this important research evolution.”

The aim of EURL ECVAM is to promote the scientific and regulatory acceptance of non-animal tests and to coordinate the independent evaluation of tests for specific purposes. Harlan CRS Cytotest Cell Research will contribute to the development of guidance documents, procedures, training materials and collaboration tools that facilitate the development, validation and acceptance of alternative methods.

Harlan CRS began as a regional provider of research models and services in the Midwestern U.S. more than 70 years ago and today is a global provider of those services.

“We have been researching new test systems in the fields of alternative toxicology, medical devices and genetic toxicology for several years,” Dr. Poth said. “Our hope is that someday we can eliminate animal testing entirely.”

Advertisement